Stuart Walter Peltz - Jan 10, 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol: PTCT
Transactions as of: Jan 10, 2023
Transactions value $: -$151,805
Form type: 4
Date filed: 1/12/2023, 03:34 PM
Previous filing: Jan 11, 2023
Next filing: Jan 26, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTCT	Common Stock	Sale	-$52.7K	-1.23K	-0.72%	$42.93	170K	Jan 10, 2023	Direct	F1
transaction	PTCT	Common Stock	Sale	-$24.5K	-571	-1.01%	$42.93	56K	Jan 10, 2023	By Spouse	F2
transaction	PTCT	Common Stock	Sale	-$52.7K	-1.19K	-0.7%	$44.36	169K	Jan 11, 2023	Direct	F1
transaction	PTCT	Common Stock	Sale	-$21.8K	-492	-0.88%	$44.36	55.5K	Jan 11, 2023	By Spouse	F2

Showing 1 to 4 of 4 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 11,000RSUs from a January 7, 2022 grant of 44,000 RSUs.
F2	Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 4,200 RSUs from a January 7, 2022 grant of 16,800 RSUs.